Eveninger reporter attacked by gang near Uppinangady

Udupi, Feb 23: Tanushree Pithrody, a 10-year-old girl from Udyavar and class 6 student of St Cecily’s School, here and a Guinness World Record holder, erased the old record by covering the 100 metres 'Chakrasana race' in one minute 14 seconds to write her name in the Golden Book of World Records.

This was announced by Manish Bishnoi, Head, Golden Book of World Records, who handed over the Certificate to Ms Tanushree, who was accompanied by her father Uday Kumar and mother Sandhya here on Saturday.

The previous record-holder in this category was Samiksha Dogra [11 years and 1 month] from Rampur Bhushar, Himachal Pradesh, who had set a time of 6 minutes and 2 seconds on June14,2018.

Later speaking to scribes here, Ms Tanushree said that she was delighted that she was able to break the record. “When I was practicing, I used to finish it in around 2 minutes. This is my fifth record. I dedicate my success to my parents and my Yoga guru,”she added.

Ms Tanushree has also created a record for the ‘most forward rolls with Dhanurasana Yoga pose in 1 minute’ by performing 62 rolls and she also created the ‘fastest 100 forward rolls with Dhanurasana Yoga pose’ in 1 minute and 40 seconds on February 23, 2019 and entered the Golden Book of World Records.

In 2018, she set the Guinness World Record for ‘most full-body revolutions maintaining a chest stand position’ with 42 full-body revolutions in one minute, and on 21 March, 2019 she broke that record with 44.

New Delhi, Mar 19: The Supreme Court on Thursday upheld the validity of Karnataka's 2018 reservation law, which granted reservation in promotion to employees belonging to SC and ST categories.

A bench headed by Justice DY Chandrachud holds that applications filed by a group of general category employees for applying 'post-based quota' and the principle of the creamy layer at entry-level in public employment are not maintainable.

The apex court had, in November last year, reserved its order on the applications filed by general category candidates in the matter.

In May last year, the top court had upheld the law allowing reservations in promotions for SC and ST candidates with consequential seniority.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.